Lv1
30 积分 2021-03-05 加入
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结
In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift
2个月前
已完结
Obecabtagene autoleucel, a novel CD19-directed CAR T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: the future for reducing toxicity and T-cell exhaustion?
5个月前
已完结
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies
6个月前
已完结
皖公网安备34019202002308
